Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Chimeric, Eucure, Gan & Lee, Geovax Labs, Incannex, Kintor, Moderna, Noxopharm, Pfizer, Prestige, Recce, Taiwan Liposome, Telix, Transcenta.